Amyloid formation: Designer proteins light the way forward

July 17, 2013
Amyloid formation: Designer proteins light the way forward
Electron microscopy images reveal that amyloids formed by the designed peptide LD6 (top left) have a similar structure to naturally occurring amyloids in diabetes type 2 (top right), Alzheimer’s disease (bottom left) and thyroid cancer (bottom right). Credit: A. Lakshmanan et al.

Insight into the mechanism of protein aggregation provides a model system that could lead to treatments for several associated diseases

The assembly of abnormal proteins into aggregates called amyloids is a characteristic of several diseases, including Alzheimer's, Parkinson's, and . Exactly how amyloids form is unknown, but work performed at A*STAR has shown that the mechanism can be accurately recreated with specifically designed .

The research team included Charlotte Hauser and Anupama Lakshmanan at the A*STAR Institute of Bioengineering and Nanotechnology (IBN), Daniel Cheong at the A*STAR Institute of High Performance Computing and international collaborators.

The study was based on previous work in which the IBN team designed peptides, or short protein fragments, that self-assemble in water to produce amyloids. In their recent study, the researchers used experimental techniques and computer modeling to compare the structural properties of aggregates formed by two of these peptides—LIVAGD (LD6) and IVD (ID3)—with those of peptide fragments from naturally occurring (see image).

"We found that our rationally designed peptides exhibit a similar self-assembly mechanism to several amyloid-forming implicated in disease," says Hauser. "This provides a fresh perspective on the process of amyloid formation."

The team also aimed to clarify the role of the amino acid phenylalanine, which is often found within regions of proteins that are important for amyloid formation. Consequently, scientists thought that phenylalanine played a crucial role in the mechanism. The team's findings, however, challenge this idea: the peptides that the researchers designed contained no phenylalanine or similar amino acids, yet still formed amyloids.

Analysis of another naturally occurring peptide, KLVFFAE (KE7), reinforced this finding. KE7 is a fragment of amyloid-?, a protein involved in Alzheimer's disease. Scientists believed that two adjacent phenylalanines in its structure were crucial for amyloid formation, but Hauser and co-workers discovered that KE7 forms aggregates in a different way to the amyloid-forming peptides.

"This suggests that phenylalanine is not as essential for amyloid formation as previously postulated," explains Hauser. "It shows that there might be other core sequences that are more important."

Hauser notes that the new study forms the basis for tackling amyloid fibril formation in disease. "The fundamental mechanism of amyloid formation is believed to be common across all amyloid-related diseases, so drugs could be developed to effectively treat multiple diseases," she explains. Insufficient knowledge of protein self-assembly has hampered the search for a way to prevent or cure amyloid formation. "Our findings put forth a simplified model to study this hallmark of several degenerative disorders and design therapeutics for its control and prevention."

Explore further: Simulating amyloid formation

More information: Proceedings of the National Academy of Sciences USA 110, 519–524 (2013). www.pnas.org/content/110/2/519.abstract

Related Stories

Simulating amyloid formation

May 4, 2011

Many neurodegenerative diseases are characterized by proteins that assume an abnormal configuration, which leads to their aggregation and deposition in and around rve cells, causing cell death. This process, called amyloid ...

Researchers watch amyloid plaques form

October 3, 2011

Researchers at the University of Toronto Scarborough (UTSC) and Osaka University applied a new approach to take a close look at amyloid plaque formation, a process that plays important roles in Alzheimer's disease. The technique ...

Understanding abnormal proteins in degenerative diseases

April 22, 2013

Amyloids, or fibrous aggregates of abnormally folded proteins, are a common feature in degenerative diseases such as Alzheimer's, diabetes and cancer. Amyloids occur naturally in the body, but despite decades of research, ...

Fighting Alzheimer's disease with protein origami

July 12, 2013

Alzheimer's disease is a progressive degenerative brain disease most commonly characterized by memory deficits. Loss of memory function, in particular, is known to be caused by neuronal damage arising from the misfolding ...

Recommended for you

Basic research fuels advanced discovery

August 26, 2016

Clinical trials and translational medicine have certainly given people hope and rapid pathways to cures for some of mankind's most troublesome diseases, but now is not the time to overlook the power of basic research, says ...

New method creates endless supply of kidney precursor cells

August 25, 2016

Salk Institute scientists have discovered the holy grail of endless youthfulness—at least when it comes to one type of human kidney precursor cell. Previous attempts to maintain cultures of the so-called nephron progenitor ...

New avenue for understanding cause of common diseases

August 25, 2016

A ground-breaking Auckland study could lead to discoveries about many common diseases such as diabetes, cancer and dementia. The new finding could also illuminate the broader role of the enigmatic mitochondria in human development.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.